Follow Us:
Tizanidine Exporter From India

Tizanidine

Tizanidine is a centrally acting muscle relaxant belonging to the alpha-2 adrenergic agonist group of medicines. It is mainly used for the treatment of muscle spasticity associated with multiple sclerosis, spinal cord injuries and other neurological disorders. It works by stimulating alpha-2 adrenergic receptors in the central nervous system, thereby reducing the release of excitatory neurotransmitters and decreasing nerve signals responsible for muscle stiffness and spasms. This helps relax muscles and improve movement. Tizanidine is available in tablet and capsule forms for oral administration. Common side effects include drowsiness, dizziness, dry mouth, weakness and low blood pressure. It may also cause liver dysfunction. It should be used only as prescribed by a healthcare professional.

  • Dosage Form:
  • Dosage Strength:
  • Manufacturer:
  • CAS No.:
  • Status:

Applications of Tizanidine

Tizanidine was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:

is okay

Contraindication of Tizanidine

Availability of Tizanidine

Delivery of Tizanidine

Frequently Asked Questions

The most frequently asked questions focus on import, export, documentations, and regulation for Tizanidine.

The is a pharmaceutical active pharmaceutical ingredient (API) used in manufacturing of Tizanidine.

: Provides active pharmaceutical ingredients (APIs), customized production, and OEM/ODM services with research and technical cooperation across Europe, the USA, and India via Primeera Healthcare.

  • Therapeutic Goods Administration (TGA):
  • US Food and Drug Administration (USFDA):
  • European Medicines Agency (EMA):
  • African Medicines Agency (AMA):
  • National Medical Products Administration (NMPA):
  • Central Drugs Standard Control Organization (CDSCO):

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Tizanidine, subject to confirmation of its current regulatory status and eligibility for import into India.

Documentation Required for Tizanidine Import

The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.

Import Regulations and dcoumentation for Tizanidine

  • Import Documentation Assistance:
    Support with organising commercial invoices, packing lists, manufacturer details, product specifications, certificates of analysis, and other relevant documents required for regulatory review and customs processing.

  • Regulatory Coordination:
    Assistance with identifying applicable CDSCO requirements, import authorisations, and documentation procedures, subject to the product's regulatory status and the proposed import route.
  • Shipping and Customs Coordination:
    Coordination with relevant logistics providers and customs professionals to organise shipment documentation and facilitate clearance where legally permitted.
  • Compliance Verification:
    Preliminary review of available product and shipment documentation to identify potential regulatory gaps before procurement or dispatch. Import arrangements will proceed only after the applicable permissions and restrictions have been verified.

Customs Clearance and Compliance Handling of Tizanidine Import

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Tizanidine, subject to confirmation of its current regulatory status and eligibility for import into India.

Export Regulations and dcoumentation for Tizanidine

The export of Tizanidine from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.

Documentation Required for Tizanidine Emport

  • Export Documentation Assistance:
    Assistance with organising commercial invoices, packing lists, manufacturer details, Tizanidine specifications, certificates of analysis, and other supporting documents required for Tizanidine export and customs processing.
  • Regulatory Coordination:
    Support in identifying applicable country specific Tizanidine export requirements, relevant manufacturing and export authorisations, and destination-country registration or import approval requirements, subject to the Tizanidine regulatory status.
  • Shipping and Customs Coordination:
    Coordination with logistics providers, freight forwarders, and customs professionals to organise shipping documentation, export declarations, and customs clearance procedures where legally permitted.
  • Compliance Verification:
    Preliminary review of available Tizanidine documentation, labelling, Tizanidine manufacturing information, and destination-market requirements to identify potential regulatory gaps before dispatch. Export arrangements will proceed only after the applicable restrictions and authorisations have been verified.

Customs Clearance and Compliance Handling of Tizanidine Export

Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Tizanidine, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.

Product Export Support

If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.